Briacell therapeutics corp.BCTX.US Overview

US StockHealthcare

(No presentation for BCTX)

Overview AI Analysis Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

BCTX Overall Performance

BCTX AI Analysis & Strategy

BCTX Recent Performance

Briacell therapeutics corp.

Avg of Sector

S&P500

BCTX PowerScanner

BCTX Key Information

BCTX Valuation Metrics

BCTX Earnings Table

BCTX Profile

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.